IL21 and systemic lupus erythematosus: There are extensive data indicating that IL-21 signaling promotes the pathogenesis of autoimmune diseases1, including in animal models of type 1 diabetes49,50, systemic lupus erythematosus (SLE)51, and experimental autoimmune uveitis52.